Discover
VRDN
Viridian Therapeutics, Inc.
18.48
2 x 13.78
2 x 23.69
bid
ask
+
0.11
0.60%
2 @ 04:00 PM
18.17 -0.31 (1.68%)
| Ytd | -40.62% | |
| 1y | 21.34% |
18.43
day range
19.34
13.18
52 week range
34.29
| Open | 18.95 | Prev Close | 18.37 | Low | 18.43 | High | 19.34 | Mkt Cap | 2.04B |
| Vol | 3.18M | Avg Vol | 2.89M | EPS | -3.35 | P/E | N/A | Forward P/E | -7.23 |
| Beta | 0.90 | Short Ratio | 8.97 | Inst. Own | 111.34% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 16.36 | 200-d Avg | 24.10 | 1yr Est | 35.50 |
| Income Statement | |||
| Total Revenue | 141.00K | ||
| Revenues (USD) | 141.00K | ||
| Gross Profit | 141.00K | ||
| Operating Expenses | 116.31M | ||
| Research and Development Expense | 77.63M | ||
| Selling, General and Administrative Expense | 38.68M | ||
| Operating Income | -116.17M | ||
| Interest Expense | 3.46M | ||
| Net Income | -104.90M | ||
| Net Income Common Stock | -104.90M | ||
| Net Income Common Stock (USD) | -104.90M | ||
| Consolidated Income | -104.90M | ||
| Earnings per Basic Share | -0.90 | ||
| Earnings per Basic Share (USD) | -0.90 | ||
| Earnings per Diluted Share | -0.90 | ||
| Earning Before Interest & Taxes (EBIT) | -101.44M | ||
| Earning Before Interest & Taxes (USD) | -101.44M | ||
| Weighted Average Shares | 102.21M | ||
| Weighted Average Shares Diluted | 102.21M | ||
| Balance Sheet | |||
| Cash and Equivalents | 176.35M | ||
| Cash and Equivalents (USD) | 176.35M | ||
| Investments | 585.84M | ||
| Investments Current | 585.84M | ||
| Current Assets | 784.74M | ||
| Property, Plant & Equipment Net | 3.39M | ||
| Total Assets | 789.02M | ||
| Total Debt | 86.53M | ||
| Current Liabilities | 51.81M | ||
| Debt Non-Current | 86.53M | ||
| Total Liabilities | 153.01M | ||
| Accumulated Retained Earnings (Deficit) | -1.44B | ||
| Accumulated Other Comprehensive Income | -558.00K | ||
| Shareholders Equity | 636.01M | ||
| Shareholders Equity (USD) | 636.01M | ||
| Assets Non-Current | 4.27M | ||
| Total Debt (USD) | 86.53M | ||
| Liabilities Non-Current | 101.20M | ||
| Trade and Non-Trade Payables | 13.31M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 121.00K | ||
| Net Cash Flow from Financing | 6.36M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -36.04M | ||
| Capital Expenditure | -23.00K | ||
| Issuance (Purchase) of Equity Shares | 6.36M | ||
| Net Cash Flow from Investing | 77.26M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 77.28M | ||
| Net Cash Flow from Operations | -119.65M | ||
| Share Based Compensation | 13.39M | ||